Please Wait.....
Report
Blockchain in Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), By Service (Utility Tokens and Blockchain Platforms), By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others), By Region and Competition, 2020-2030F
Market Report I 2025-08-06 I 188 Pages I TechSci Research
Market Overview
Global Blockchain in Genomics Market was valued at USD 1.06 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.11% through 2030. Blockchain is a digital public ledger that securely records transactions and data in units known as blocks. For instane, in 2022, the FDA's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Of the 35 therapeutic NMEs, 12-around 34 percent-were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the growing emphasis on tailoring treatments based on individual genetic, biomarker, or molecular profiles to improve therapeutic outcomes and reduce adverse effects. Each block is timestamped and linked to the previous one, forming an immutable chain that cannot be altered retroactively. This decentralized framework allows data to be distributed across a network of interconnected systems without relying on a central authority, enhancing transparency and reliability. With global accessibility enabled through proper authorization, users maintain control over their data, ensuring privacy and security.
Key Market Drivers
Rising Investment by Private Players and Venture Capitalists
Increased investment provides researchers and innovators with the financial resources needed to explore and develop blockchain solutions tailored for genomics. This funding supports the creation of new platforms, tools, and applications that leverage blockchain's capabilities. For instance, in March 2024, MENADNA Inc., a prominent bioinformatics and genetic testing startup focused on the Middle East and North Africa (MENA) region, announced an exclusive partnership with Nebula Genomics, a leader in personalized genome sequencing. Under this agreement, MENADNA becomes Nebula's exclusive partner in Jordan, Oman, and Iraq. Currently active in the UAE, MENADNA also plans to expand into Saudi Arabia. The collaboration aims to enhance the region's representation in genomic research by combining Nebula's cutting-edge sequencing technology with MENADNA's proprietary bioinformatics platform, addressing a long-standing gap in global genome-wide association studies. Financial support from private players and venture capitalists accelerates the development of blockchain-based solutions for genomics. This leads to quicker advancements in technology, making blockchain more accessible and applicable to genomic research and data management. Funding supports the development of robust and scalable blockchain infrastructure required to handle large volumes of genomic data securely. This infrastructure enables efficient data storage, sharing, and analysis. Investments attract collaboration among stakeholders, including researchers, industry players, technology providers, and healthcare institutions. These partnerships foster a collaborative ecosystem that accelerates blockchain adoption in genomics. Venture capital investment fuels the growth of genomics-focused start-ups that are developing blockchain solutions. These start-ups contribute to the development of new platforms, tools, and applications, increasing the overall demand for blockchain technology. Investment in blockchain technology enables the streamlining of clinical trials, data sharing, and research collaboration. This leads to more efficient and cost-effective research efforts in genomics. Increasing investments from private players and venture capitalists are contributing to the growth of the Blockchain in Genomic Data Management Market. Recent developments in this field, such as strategic partnerships involving pharmaceutical companies and government bodies, as well as investments from venture capital and other stakeholders, indicate the growing acceptance of blockchain platforms for the storage and management of genetic information in the healthcare industry. These collective efforts will significantly drive the market's growth in the years to come.
Key Market Challenges
Regulatory Challenges
The use of blockchain technology in genomics presents several regulatory challenges that need to be addressed to ensure compliance with existing laws and ethical standards. These challenges stem from the unique nature of genomic data, data privacy concerns, data ownership, and the decentralized nature of blockchain. Genomic data is highly sensitive and personal. Regulatory frameworks, such as the General Data Protection Regulation (GDPR) in the European Union, require strict adherence to data privacy principles. Ensuring that individuals provide informed and explicit consent for their data to be stored, shared, and used on the blockchain is a significant challenge. Blockchain's decentralized nature challenges traditional concepts of data ownership. Determining who has control over genomic data stored on the blockchain and how individuals can assert their rights over their data is a regulatory hurdle. Integrating blockchain into existing regulatory frameworks designed for centralized systems can be difficult. Regulators must adapt or create new regulations that accommodate the unique characteristics of blockchain technology.
Key Market Trends
Innovations in Technology
Innovation in blockchain technology within the field of genomics has the potential to significantly boost its demand in the future by addressing existing challenges, enhancing data management, improving research collaboration, and enabling new possibilities for personalized medicine. Innovative blockchain solutions can offer even stronger data security and privacy features, assuaging concerns about the safe storage and sharing of sensitive genomic data. This can encourage more individuals to contribute their data for research and clinical purposes. Blockchain innovations can introduce advanced consent management and data ownership mechanisms. Individuals will have greater control over their genetic data, leading to increased willingness to participate in research initiatives. Innovative blockchain platforms can facilitate secure cross-border data sharing and collaboration among researchers and institutions. This can accelerate the pace of genomics research by allowing global participation and knowledge exchange. As blockchain technology continues to evolve and new innovations emerge, the demand for its integration in genomics is likely to grow. These innovations can address critical concerns, unlock new research opportunities, and ultimately lead to improved patient care, driving the adoption and utilization of blockchain technology in the field of genomics.
Key Market Player
- Oxford Nanopore Technologies Plc
- PacBio (Pacific Biosciences of California Inc.)
- Guardtime Ltd.
- Agilent Technologies Inc.
- Illumina Inc.
- BioRad Laboratories Inc.
- 10x Genomics Inc.
- QIAGEN NV
- Nebula Genomics Inc.
- Thermo Fisher Scientific.
Report Scope:
In this report, the Global Blockchain in Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Blockchain in Genomics Market, By Business Model:
o B2B Business Model
o B2C Business Model
o C2B Business Model
- Blockchain in Genomics Market, By Service:
o Utility Tokens
o Blockchain Platforms
- Blockchain in Genomics Market, By Application:
o Data Sharing & Monetization
o Data Storage & Security
o Automated Health Insurance
- Blockchain in Genomics Market, By End User:
o Pharmaceutical & Biotechnology Companies
o Hospitals & Healthcare Providers
o Research Institutes
o Data Owners
o Others
- Blockchain in Genomics Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Blockchain in Genomics Market.
Available Customizations:
Global Blockchain in Genomics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Blockchain in Genomics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model)
5.2.2. By Service (Utility Tokens and Blockchain Platforms)
5.2.3. By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance)
5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Blockchain in Genomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Business Model
6.2.2. By Service
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Blockchain in Genomics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Business Model
6.3.1.2.2. By Service
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Blockchain in Genomics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Business Model
6.3.2.2.2. By Service
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Blockchain in Genomics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Business Model
6.3.3.2.2. By Service
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Blockchain in Genomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Business Model
7.2.2. By Service
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Blockchain in Genomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Business Model
7.3.1.2.2. By Service
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. United Kingdom Blockchain in Genomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Business Model
7.3.2.2.2. By Service
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Italy Blockchain in Genomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Business Model
7.3.3.2.2. By Service
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. France Blockchain in Genomics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Business Model
7.3.4.2.2. By Service
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Blockchain in Genomics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Business Model
7.3.5.2.2. By Service
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Blockchain in Genomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Business Model
8.2.2. By Service
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Blockchain in Genomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Business Model
8.3.1.2.2. By Service
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Blockchain in Genomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Business Model
8.3.2.2.2. By Service
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Blockchain in Genomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Business Model
8.3.3.2.2. By Service
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Blockchain in Genomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Business Model
8.3.4.2.2. By Service
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Blockchain in Genomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Business Model
8.3.5.2.2. By Service
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Blockchain in Genomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Business Model
9.2.2. By Service
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Blockchain in Genomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Business Model
9.3.1.2.2. By Service
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Blockchain in Genomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Business Model
9.3.2.2.2. By Service
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Blockchain in Genomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Business Model
9.3.3.2.2. By Service
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Blockchain in Genomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Business Model
10.2.2. By Service
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Blockchain in Genomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Business Model
10.3.1.2.2. By Service
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Blockchain in Genomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Business Model
10.3.2.2.2. By Service
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Blockchain in Genomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Business Model
10.3.3.2.2. By Service
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Oxford Nanopore Technologies Plc
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. PacBio (Pacific Biosciences of California Inc.)
14.3. Guardtime Ltd.
14.4. Agilent Technologies Inc.
14.5. Illumina Inc.
14.6. BioRad Laboratories Inc.
14.7. 10x Genomics Inc.
14.8. QIAGEN NV
14.9. Nebula Genomics Inc.
14.10. Thermo Fisher Scientific
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security